Cargando…
Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review
Background: Tuberculosis, like COVID-19, is most often a pulmonary disease. The COVID-19 pandemic has severely disrupted tuberculosis services in myriad ways: health facility closures, lockdowns, travel bans, overwhelmed healthcare systems, restricted export of antituberculous drugs, etc. The effect...
Autores principales: | Jhaveri, Tulip A., Fung, Celia, LaHood, Allison N., Lindeborg, Andrew, Zeng, Chengbo, Rahman, Rifat, Bain, Paul A., Velásquez, Gustavo E., Mitnick, Carole D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570663/ https://www.ncbi.nlm.nih.gov/pubmed/36233523 http://dx.doi.org/10.3390/jcm11195656 |
Ejemplares similares
-
Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different
por: LaHood, Allison, et al.
Publicado: (2022) -
Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru
por: Rahman, Rifat S, et al.
Publicado: (2023) -
TB research requires strong protections, innovation, and increased funding in response to COVID-19
por: Nyang’wa, B. T., et al.
Publicado: (2021) -
Prevention and management of hearing loss in patients receiving ototoxic medications
por: Lindeborg, Michael M, et al.
Publicado: (2022) -
Closing gaps in the tuberculosis care cascade: an action-oriented research agenda
por: Subbaraman, Ramnath, et al.
Publicado: (2020)